what is a microdose of retatrutide Significantly Reduces Visceral Fat in Clinical Trials Retatrutide—A Game Changer in Obesity
Description
The present study revealed significantly improved survival among NEN patients receiving GLP-1Ra therapy
Little to no weight change initially: Significant weight loss typically becomes more evident from weeks four to eight onwards, as the dose is increased and the body responds to sustained appetite reduction
Retatrutide helps support fat loss by reducing appetite, increasing fullness, and making it easier to maintain a calorie deficit
To get it in your inbox, subscribe here
Nagakawa K
